# Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

> **NCT02242318** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 440 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Valsartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02242318
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2002-09
- **Final completion:** —
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242318, "Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02242318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*